Published in J Acquir Immune Defic Syndr on April 15, 2012
Cognitive Training for the Remediation of Functional Brain Health in HIV | NCT02571504
Pathways to neurodegeneration: effects of HIV and aging on resting-state functional connectivity. Neurology (2013) 1.82
HIV-associated neurocognitive disorder. Lancet Infect Dis (2013) 1.60
Neuroimaging studies of the aging HIV-1-infected brain. J Neurovirol (2012) 1.23
Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection. PLoS One (2014) 1.12
Mapping white matter integrity in elderly people with HIV. Hum Brain Mapp (2013) 1.05
Accelerated aging of selective brain structures in human immunodeficiency virus infection: a controlled, longitudinal magnetic resonance imaging study. Neurobiol Aging (2014) 1.05
Neuroimaging markers of human immunodeficiency virus infection in South Africa. J Neurovirol (2012) 0.95
HIV and aging: effects on the central nervous system. Semin Neurol (2014) 0.92
Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C disease. J Neurovirol (2014) 0.91
HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease? Alzheimers Res Ther (2015) 0.89
Activation of TRPML1 clears intraneuronal Aβ in preclinical models of HIV infection. J Neurosci (2014) 0.88
Role of neuroimaging in HIV-associated neurocognitive disorders. Semin Neurol (2014) 0.88
Neuroimaging of HIV-associated neurocognitive disorders (HAND). Curr Opin HIV AIDS (2014) 0.88
Visuospatial temporal order memory deficits in older adults with HIV infection. Cogn Behav Neurol (2013) 0.88
HIV clades B and C are associated with reduced brain volumetrics. J Neurovirol (2013) 0.88
The HIV-1 transgenic rat model of neuroHIV. Brain Behav Immun (2015) 0.87
Weighted brain networks in disease: centrality and entropy in human immunodeficiency virus and aging. Neurobiol Aging (2014) 0.86
Physical Activity is Associated with Better Neurocognitive and Everyday Functioning Among Older Adults with HIV Disease. AIDS Behav (2015) 0.85
Select neurocognitive impairment in HIV-infected women: associations with HIV viral load, hepatitis C virus, and depression, but not leukocyte telomere length. PLoS One (2014) 0.83
Effects of HIV and combination antiretroviral therapy on cortico-striatal functional connectivity. AIDS (2015) 0.83
Psychological factors, including alexithymia, in the prediction of cardiovascular risk in HIV infected patients: results of a cohort study. PLoS One (2013) 0.83
Neurologic Complications and Considerations in HIV-Infected Persons. Curr Infect Dis Rep (2013) 0.83
Human immunodeficiency virus-associated dementia: a link between accumulation of viral proteins and neuronal degeneration. Curr Trends Neurol (2015) 0.82
Co-morbidity, ageing and predicted mortality in antiretroviral treated Australian men: a quantitative analysis. PLoS One (2013) 0.81
White matter fiber compromise contributes differentially to attention and emotion processing impairment in alcoholism, HIV-infection, and their comorbidity. Neuropsychologia (2012) 0.81
Distal sensory polyneuropathy is associated with neuropsychological test performance among persons with HIV. J Int Neuropsychol Soc (2012) 0.81
Neural dysregulation during a working memory task in human immunodeficiency virus-seropositive and hepatitis C coinfected individuals. J Neurovirol (2014) 0.81
Effects of information processing speed on learning, memory, and executive functioning in people living with HIV/AIDS. J Clin Exp Neuropsychol (2014) 0.81
Reduced neural specificity in middle-aged HIV+ women in the absence of behavioral deficits. Neuroimage Clin (2014) 0.81
Deformed Subcortical Structures Are Related to Past HIV Disease Severity in Youth With Perinatally Acquired HIV Infection. J Pediatric Infect Dis Soc (2016) 0.80
Mapping abnormal subcortical brain morphometry in an elderly HIV + cohort. Neuroimage Clin (2015) 0.80
Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals. J Neurovirol (2016) 0.80
HIV infection is associated with attenuated frontostriatal intrinsic connectivity: a preliminary study. J Int Neuropsychol Soc (2015) 0.80
Age exacerbates HIV-associated white matter abnormalities. J Neurovirol (2015) 0.80
The Effect of Central Nervous System Penetration Effectiveness of Highly Active Antiretroviral Therapy on Neuropsychological Performance and Neuroimaging in HIV Infected Individuals. J Neuroimmune Pharmacol (2015) 0.79
Prefrontal cortical thinning in HIV infection is associated with impaired striatal functioning. J Neural Transm (Vienna) (2016) 0.78
Facial emotion recognition impairments are associated with brain volume abnormalities in individuals with HIV. Neuropsychologia (2015) 0.78
Early suppressive antiretroviral therapy in HIV infection is associated with measurable changes in the corpus callosum. J Neurovirol (2014) 0.78
Human immunodeficiency virus has similar effects on brain volumetrics and cognition in males and females. J Neurovirol (2015) 0.78
Prefrontal cortical volume loss is associated with stress-related deficits in verbal learning and memory in HIV-infected women. Neurobiol Dis (2015) 0.78
Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention - A Comparison with Parkinson's Disease. Neuropsychol Rev (2015) 0.78
Increased brain-predicted aging in treated HIV disease. Neurology (2017) 0.77
Corpus callosum thickness on mid-sagittal MRI as a marker of brain volume: a pilot study in children with HIV-related brain disease and controls. Pediatr Radiol (2015) 0.77
Effects of HIV and childhood trauma on brain morphometry and neurocognitive function. J Neurovirol (2015) 0.77
Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era. J Acquir Immune Defic Syndr (2016) 0.76
Neuroimaging abnormalities in clade C HIV are independent of Tat genetic diversity. J Neurovirol (2016) 0.76
Shallow encoding and forgetting are associated with dependence in instrumental activities of daily living among older adults living with HIV infection. Arch Clin Neuropsychol (2014) 0.76
Expression of gp120 in mice evokes anxiety behavior: Co-occurrence with increased dendritic spines and brain-derived neurotrophic factor in the amygdala. Brain Behav Immun (2016) 0.76
The Washington University Central Neuroimaging Data Archive. Neuroimage (2015) 0.76
Progressive Brain Atrophy Despite Persistent Viral Suppression in HIV Over Age 60. J Acquir Immune Defic Syndr (2017) 0.76
Visceral fat is associated with brain structure independent of human immunodeficiency virus infection status. J Neurovirol (2016) 0.75
Lower Total and Regional Grey Matter Brain Volumes in Youth with Perinatally-Acquired HIV Infection: Associations with HIV Disease Severity, Substance Use, and Cognition. Brain Behav Immun (2017) 0.75
Putamen volume and its clinical and neurological correlates in primary HIV infection. AIDS (2016) 0.75
Extracting patterns of morphometry distinguishing HIV associated neurodegeneration from mild cognitive impairment via group cardinality constrained classification. Hum Brain Mapp (2016) 0.75
Physical Activity Affects Brain Integrity in HIV+ Individuals. J Int Neuropsychol Soc (2015) 0.75
Impairments in Component Processes of Executive Function and Episodic Memory in Alcoholism, HIV Infection, and HIV Infection with Alcoholism Comorbidity. Alcohol Clin Exp Res (2016) 0.75
The effects of HIV and aging on subcortical shape alterations: A 3D morphometric study. Hum Brain Mapp (2016) 0.75
Topological organization of whole-brain white matter in HIV infection. Brain Connect (2017) 0.75
Regionally Specific Brain Volumetric and Cortical Thickness Changes in HIV-Infected Patients in the HAART Era. J Acquir Immune Defic Syndr (2017) 0.75
Cross-sectional study of unexplained white matter lesions in HIV positive individuals undergoing brain magnetic resonance imaging. AIDS Patient Care STDS (2014) 0.75
STD Clinic Patients' Awareness of Non-AIDS Complications of HIV Infection. J Int Assoc Provid AIDS Care (2014) 0.75
High early life stress and aberrant amygdala activity: risk factors for elevated neuropsychiatric symptoms in HIV+ adults. Brain Imaging Behav (2016) 0.75
Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer's Disease: an Emerging Issue in Geriatric NeuroHIV. Curr HIV/AIDS Rep (2017) 0.75
Mechanisms of Cognitive Aging in the HIV-Positive Adult. Curr Behav Neurosci Rep (2017) 0.75
Corpus callosum thickness in children: an MR pattern-recognition approach on the midsagittal image. Pediatr Radiol (2014) 0.75
Correlating brain volume and callosal thickness with clinical and laboratory indicators of disease severity in children with HIV-related brain disease. Childs Nerv Syst (2014) 0.75
Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron (2002) 33.99
Sequence-independent segmentation of magnetic resonance images. Neuroimage (2004) 11.36
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol (2010) 7.56
HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med (2011) 6.30
Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis (2008) 4.46
Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol (1997) 3.38
Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS (2007) 3.04
Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS (2009) 2.88
HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci (2007) 2.75
3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry. Neuroimage (2006) 2.69
Generalized tensor-based morphometry of HIV/AIDS using multivariate statistics on deformation tensors. IEEE Trans Med Imaging (2008) 2.46
Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology (2010) 2.40
Neurologic complications of HIV disease and their treatment. Top HIV Med (2010) 2.14
AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol (1995) 2.14
Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS (2011) 2.04
Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. J Neurovirol (2010) 1.95
3D mapping of ventricular and corpus callosum abnormalities in HIV/AIDS. Neuroimage (2006) 1.93
Multiple testing with minimal assumptions. Biom J (2008) 1.87
Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review. Neuropsychol Rev (2009) 1.73
Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr (2009) 1.69
Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology (1993) 1.68
Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. Arch Neurol (1998) 1.66
Differential aging of the human striatum: longitudinal evidence. AJNR Am J Neuroradiol (2003) 1.65
Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss. Arch Neurol (2004) 1.65
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology (2011) 1.65
Choosing among generalized linear models applied to medical data. Stat Med (1998) 1.64
Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy. J Neurovirol (2009) 1.57
Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol (2011) 1.57
Subcortical brain atrophy persists even in HAART-regulated HIV disease. Brain Imaging Behav (2011) 1.53
Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group. Arch Neurol (1993) 1.45
Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients. Neurology (2006) 1.42
Fitting piecewise linear regression functions to biological responses. J Appl Physiol (1985) (1989) 1.41
HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging. J Infect Dis (2010) 1.40
Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity. J Neuropsychiatry Clin Neurosci (2007) 1.39
Lower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorder. J Magn Reson Imaging (2010) 1.35
Contribution of alcoholism to brain dysmorphology in HIV infection: effects on the ventricles and corpus callosum. Neuroimage (2006) 1.31
Impact of apolipoprotein E ε4 and HIV on cognition and brain atrophy: antagonistic pleiotropy and premature brain aging. Neuroimage (2011) 1.29
Reliability and validity of MRI-based automated volumetry software relative to auto-assisted manual measurement of subcortical structures in HIV-infected patients from a multisite study. Neuroimage (2010) 1.29
Factors affecting brain structure in men with HIV disease in the post-HAART era. Neuroradiology (2011) 1.27
Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV. J Int Neuropsychol Soc (2008) 1.26
Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes. J Neurovirol (2010) 1.22
HIV, antiretroviral therapies, and the brain. Curr HIV/AIDS Rep (2010) 1.20
Aging and HIV infection: a comparison between older HIV-infected persons and the general population. HIV Clin Trials (2010) 1.16
Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients. J Neurovirol (2006) 1.14
Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Parkinsonism Relat Disord (2011) 1.11
The relationship of quantitative brain magnetic resonance imaging measures to neuropathologic indexes of human immunodeficiency virus infection. Arch Neurol (1994) 1.09
Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders. Mol Brain (2011) 1.08
Neuropsychological performance in HIV-1 immunocompromised patients: a preliminary report. J Clin Exp Neuropsychol (1989) 1.01
A review of premature frailty in HIV-infected persons; another manifestation of HIV-related accelerated aging. Curr Aging Sci (2011) 1.00
Voxel-based morphometry of sporadic epileptic patients with mesiotemporal sclerosis. Epilepsia (2009) 0.96
Brain atrophy in HIV infection is more strongly associated with CDC clinical stage than with cognitive impairment. J Int Neuropsychol Soc (1997) 0.95
Magnetic resonance imaging findings in HIV cognitive impairment. Arch Neurol (1990) 0.94
Parallel high throughput neuronal toxicity assays demonstrate uncoupling between loss of mitochondrial membrane potential and neuronal damage in a model of HIV-induced neurodegeneration. Neurosci Res (2011) 0.93
Mapping cerebellar degeneration in HIV/AIDS. Neuroreport (2008) 0.93
HIV-1 proviral DNA load across neuroanatomic regions of individuals with evidence for HIV-1-associated dementia. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.93
Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals. Curr Opin Investig Drugs (2010) 0.91
Asymptomatic and neurologically symptomatic HIV-seropositive subjects: results of long-term MR imaging and clinical follow-up. Radiology (1993) 0.81
Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial. JAMA (2002) 2.96
Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol (2010) 2.91
CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS (2011) 2.31
Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patients. J Infect Dis (2010) 2.15
Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version. J Clin Exp Neuropsychol (2011) 2.06
Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial. Lancet Infect Dis (2012) 2.01
Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. J Neurovirol (2010) 1.95
Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology (2008) 1.94
Impaired replication capacity of acute/early viruses in persons who become HIV controllers. J Virol (2010) 1.80
Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection--The Hawaii Aging with HIV Cohort. J Neurovirol (2006) 1.76
Cognitive function predicts weight loss after bariatric surgery. Surg Obes Relat Dis (2011) 1.69
Antiretroviral monocyte efficacy score linked to cognitive impairment in HIV. Antivir Ther (2012) 1.64
Cognitive function predicts 24-month weight loss success after bariatric surgery. Surg Obes Relat Dis (2013) 1.50
Clinical outcomes after an unstructured treatment interruption in children and adolescents with perinatally acquired HIV infection. Pediatrics (2008) 1.47
Tolerability and efficacy of PI versus NNRTI-based regimens in subjects receiving HAART during acute or early HIV infection. J Acquir Immune Defic Syndr (2009) 1.46
Randomized controlled trial of emergency transjugular intrahepatic portosystemic shunt versus emergency portacaval shunt treatment of acute bleeding esophageal varices in cirrhosis. J Gastrointest Surg (2012) 1.45
Cognitive function and neurodevelopmental outcomes in HIV-infected Children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study. Pediatr Infect Dis J (2013) 1.43
HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging. J Infect Dis (2010) 1.40
An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of Aβ. J Neurosci (2012) 1.36
Synergy of small molecular inhibitors of hepatitis C virus replication directed at multiple viral targets. J Virol (2006) 1.33
Screening for cognitive impairment in human immunodeficiency virus. Clin Infect Dis (2011) 1.30
Apoptosis is essential for neutrophil functional shutdown and determines tissue damage in experimental pneumococcal meningitis. PLoS Pathog (2009) 1.30
Brain behavior relationships among African Americans, whites, and Hispanics. Alzheimer Dis Assoc Disord (2008) 1.30
Neurocognitive consequences of HIV in southern India: a preliminary study of clade C virus. J Int Neuropsychol Soc (2006) 1.30
HIV infection and dementia in older adults. Clin Infect Dis (2006) 1.28
Natural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitors. Antimicrob Agents Chemother (2009) 1.27
HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients. PLoS One (2013) 1.27
The Effects of Age and HIV on Neuropsychological Performance. J Int Neuropsychol Soc (2010) 1.25
Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes. J Neurovirol (2010) 1.22
HIV proviral DNA associated with decreased neuropsychological function. J Neuropsychiatry Clin Neurosci (2007) 1.16
Modelling HIV viral rebound using non-linear mixed effects models. Stat Med (2002) 1.14
Age and temporal trends of total physical activity in Swedish men. Med Sci Sports Exerc (2003) 1.12
Validity of the International HIV Dementia Scale in South Africa. AIDS Patient Care STDS (2011) 1.11
Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults. Drug Alcohol Depend (2009) 1.08
Improved memory function two years after bariatric surgery. Obesity (Silver Spring) (2013) 1.08
Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus-infected Thais from the 2NN Cohort Study. J Neurovirol (2010) 1.07
HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence. AIDS Behav (2012) 1.06
Cognitive and motor impairments predict functional declines in patients with vascular dementia. Int J Geriatr Psychiatry (2002) 1.06
Lifetime suicidal ideation and attempt are common among HIV+ individuals. J Affect Disord (2011) 1.06
Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder. Clin Infect Dis (2013) 1.05
NeuroAIDS in Africa. J Neurovirol (2010) 1.05
HIV DNA and dementia in treatment-naïve HIV-1-infected individuals in Bangkok, Thailand. Int J Med Sci (2006) 1.04
Body mass index and neurocognitive functioning across the adult lifespan. Neuropsychology (2013) 1.04
Protein expression pattern in experimental pneumococcal meningitis. Microbes Infect (2006) 1.04
Random changepoint modelling of HIV immunologic responses. Stat Med (2007) 1.02
Development and validation of a World-Wide-Web-based neurocognitive assessment battery: WebNeuro. Behav Res Methods (2007) 1.02
Neuroimaging signatures and cognitive correlates of the montreal cognitive assessment screen in a nonclinical elderly sample. Arch Clin Neuropsychol (2011) 1.01
Role of metabolic syndrome components in human immunodeficiency virus-associated stroke. J Neurovirol (2009) 1.01
Spontaneous alpha peak frequency predicts working memory performance across the age span. Int J Psychophysiol (2004) 1.01
Test-retest stability of calibrated BOLD-fMRI in HIV- and HIV+ subjects. Neuroimage (2010) 1.00
Combined topical and intracameral anesthesia in penetrating keratoplasty. Cornea (2004) 0.99
A diffusion tensor imaging and neurocognitive study of HIV-positive children who are HAART-naïve "slow progressors". J Neurovirol (2012) 0.99
Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1. Antimicrob Agents Chemother (2010) 0.98
Cognitive function in morbidly obese individuals with and without binge eating disorder. Compr Psychiatry (2011) 0.97
Randomized trial of emergency endoscopic sclerotherapy versus emergency portacaval shunt for acutely bleeding esophageal varices in cirrhosis. J Am Coll Surg (2009) 0.97
Performances on the CogState and standard neuropsychological batteries among HIV patients without dementia. AIDS Behav (2011) 0.96
The Alzheimer's disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons. J Neurovirol (2013) 0.96
Neuroimaging markers of human immunodeficiency virus infection in South Africa. J Neurovirol (2012) 0.95
Role of metabolic syndrome components in HIV-associated sensory neuropathy. AIDS (2009) 0.95
Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV. AIDS Care (2014) 0.93
Changes in the slope of the CD4 cell count increase after initiation of potent antiretroviral treatment. J Acquir Immune Defic Syndr (2006) 0.93
Development of normative neuropsychological performance in Thailand for the assessment of HIV-associated neurocognitive disorders. J Clin Exp Neuropsychol (2012) 0.92
Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C disease. J Neurovirol (2014) 0.91
MyD88-dependent immune response contributes to hearing loss in experimental pneumococcal meningitis. J Infect Dis (2007) 0.91
Late traumatic displacement of laser in situ keratomileusis flaps. Cornea (2003) 0.91
Approaches to identifying appropriate medication adherence assessments for HIV infected individuals with comorbid bipolar disorder. AIDS Patient Care STDS (2012) 0.89
HIV and chronic methamphetamine dependence affect cerebral blood flow. J Neuroimmune Pharmacol (2011) 0.89
Health-related quality of life 'well-being' in HIV distal neuropathic pain is more strongly associated with depression severity than with pain intensity. Psychosomatics (2012) 0.89
Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings. J Int Neuropsychol Soc (2010) 0.88
HIV clades B and C are associated with reduced brain volumetrics. J Neurovirol (2013) 0.88
A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086. J Infect Dis (2006) 0.88
Portal-systemic encephalopathy in a randomized controlled trial of endoscopic sclerotherapy versus emergency portacaval shunt treatment of acutely bleeding esophageal varices in cirrhosis. Ann Surg (2009) 0.88
A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men. Brain Res (2011) 0.88
Cross-sectional study to evaluate factors associated with adherence to antiretroviral therapy by Brazilian HIV-infected patients. AIDS Res Hum Retroviruses (2006) 0.87
P. falciparum enhances HIV replication in an experimental malaria challenge system. PLoS One (2012) 0.87
White matter micro-structural changes in ART-naive and ART-treated children and adolescents infected with HIV in South Africa. AIDS (2015) 0.86
Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection. AIDS (2014) 0.86
Neuropsychological performance in mainland china: the effect of urban/rural residence and self-reported daily academic skill use. J Int Neuropsychol Soc (2010) 0.85
The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection. J Infect Dis (2010) 0.85
Perinatal immunization education improves immunization rates and knowledge: a randomized controlled trial. Prev Med (2013) 0.84
A diffusion tensor imaging and neuropsychological study of prospective memory impairment in South African HIV positive individuals. Metab Brain Dis (2012) 0.84
Neuropsychological outcomes in adults commencing highly active anti-retroviral treatment in South Africa: a prospective study. BMC Infect Dis (2012) 0.84
Prepulse inhibition in HIV-associated neurocognitive disorders. J Int Neuropsychol Soc (2013) 0.83
Condom use behaviours and correlates of use in the Botswana Defence Force. Int J STD AIDS (2013) 0.83
Impulsivity and verbal deficits associated with domestic violence. J Int Neuropsychol Soc (2003) 0.83
Child-Turcotte score versus MELD for prognosis in a randomized controlled trial of emergency treatment of bleeding esophageal varices in cirrhosis. J Surg Res (2012) 0.83
Brain Imaging and Neurodevelopment in HIV-uninfected Thai Children Born to HIV-infected Mothers. Pediatr Infect Dis J (2015) 0.82
HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter. J Neurovirol (2014) 0.81
Association between brain volumes and HAND in cART-naïve HIV+ individuals from Thailand. J Neurovirol (2015) 0.81
Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons. J Neuropsychiatry Clin Neurosci (2011) 0.81
Hypertonic saline as a therapy for pediatric concussive pain: a randomized controlled trial of symptom treatment in the emergency department. Pediatr Emerg Care (2014) 0.81
Effects of Marathi-Hindi bilingualism on neuropsychological performance. J Int Neuropsychol Soc (2011) 0.80
Neuropsychological Impairment in Acute HIV and the Effect of Immediate Antiretroviral Therapy. J Acquir Immune Defic Syndr (2015) 0.80
Cause-specific effects of radiotherapy and lymphadenectomy in stage I-II endometrial cancer: a population-based study. J Natl Cancer Inst (2013) 0.79
The therapeutic lamp: treating small-animal phobias. IEEE Comput Graph Appl (2014) 0.79
Total vertex craniopagus with crossed venous drainage: case report of successful surgical separation. Childs Nerv Syst (2004) 0.79